title: [Immunosuppressive treatment of Behçet's disease (author's transl)].
abstract: Report on the results of immunsuppressive therapy in 6 patients with Behçet's disease. A combined regimen of azathioprine and cortisone improved the course of the disease and diminished the number of recidives. In order to prevent irreversible damage to the eye early immunosuppressive therapy is advocated. Because of possible side-effects of azathioprine the necessity of further treatment should be reevaluated after several months without symptoms and then gradually terminated.
mesh_terms: D001379:Azathioprine / Q000494:pharmacology / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D003348:Cortisone / Q000494:pharmacology / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine; D003348:Cortisone
vernacular_title: Die immunsuppressive Behandlung der Behçetschen Erkrankung.